Eargo 7 vs Otofonix Groove

The Eargo 7 is a premium-priced OTC hearing aid at $2,550, featuring an invisible-in-ear design with rechargeable batteries. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.5/5, placing it in the top 57% of the OTC hearing aid category. Speech performance in quiet environments is a strength for the Eargo 7, scoring 3.1/5—0.33 points above the category average. Own-voice comfort also exceeds the category average by 0.39 points, though at 2.9/5 it remains mixed in absolute terms. However, speech understanding in noisy environments presents a limitation, scoring 1.0/5, which falls 0.44 points below the category average. A significant drawback is the complete absence of music streaming capability, scoring 0.0/5—nearly 2 points below the category average. Feedback handling is solid at 3.8/5 in absolute terms, though it falls 0.74 points below the category average for OTC devices. The Eargo 7 may appeal to users who prioritize a discreet, nearly invisible form factor and primarily need assistance in quieter listening situations. However, consumers seeking strong noise performance or music streaming should be aware of these limitations, particularly given the premium price point. Several alternatives at lower price points achieve higher overall scores in our testing.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.